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During a resurgence of measles in São Paulo, Brazil, in 1997, >40,000 cases (peak incidence rate of 246/
100,000 inhabitants) and 42 measles-related deaths were reported. Reverse transcriptase-polymerase
chain reaction and nucleotide sequencing were used to analyze specimens from patients who had typical
clinical measles infection during this outbreak and from six patients who had had measles in 1995 and
1996. Although wild-type measles viruses (genotypes D5 and D6) were present in São Paulo before this
resurgence, we detected only D6 viruses. The genotype D6 viruses isolated during this outbreak had iden-
tical sequences to genotype D6 viruses isolated in other parts of Brazil and South America in 1997 and
1998, suggesting that a single chain of transmission was responsible. We also identified genotype A
viruses in two vaccine-associated cases from 1995 and 1996. Our findings extend the knowledge of the cir-
culation patterns of measles virus in South America, contributing to measles control efforts in the Americas. 
he Pan American Health Organization (PAHO) reported
record low numbers of measles cases for 2000–2001,
reflecting the success of measles control programs in the West-
ern Hemisphere (1). In the most populous country in the
region, the United States, indigenous transmission of measles
virus has been eliminated since 1993, and only 3 of 41 coun-
tries in the region reported indigenous measles transmission
during 2001 (1,2). Despite this success, measles remains an
endemic disease in many areas of the world. The World Health
Organization (WHO) estimates that approximately 45 million
cases of measles and >800,000 measles-related deaths con-
tinue to occur annually (3,4). Sporadic measles outbreaks still
occur in both developed and undeveloped countries that have
failed to maintain adequate immunization levels. These out-
breaks, such as the one that occurred in São Paulo, Brazil, in
1997, provide an opportunity to study the virologic and epide-
miologic aspects of measles transmission in vaccinated popu-
lations. 
Before the introduction of vaccine, measles was a substan-
tial public health problem in Brazil, representing a major cause
of death among young children. Even after the introduction of
vaccine, measles epidemics continued to occur in Brazil. For
example, the epidemics of 1984 and 1986 had incidence rates
of 63/100,000 and 97/100,000, respectively. PAHO launched
an aggressive measles control program for the Americas in
1991 that included one-time national catch-up campaigns for
all children, routine “keep-up” vaccination of infants at 1 year
of age, and follow-up campaigns at 3- to 5-year intervals. In
Brazil, this strategy resulted in a 93% reduction in the inci-
dence of measles in Brazil from 1991 through 1996. For the 4-
year period 1993–1996, <1,000 cases were reported annually.
However, during the resurgence of measles in 1997 in São
Paulo, 42,055 confirmed cases of measles (23,907 laboratory
confirmed), were reported, with a peak incidence rate of 246/
100,000 inhabitants. Most of the cases were in adults living in
metropolitan São Paulo. Forty-two deaths caused by measles
were reported during this epidemic (5–7).
Virologic surveillance can help to identify the transmission
pathways of measles virus and is an important component of
measles surveillance activities (8–10). Sequence analysis of
measles viruses has shown that distinct lineages of wild-type
viruses exist and co-circulate, and WHO currently recognizes
20 measles genotypes (11–13). The epidemiologic aspects of
the measles outbreak in São Paulo have been described (5–7).
The purpose of this report is to present the genetic characteris-
tics of the measles viruses responsible for the resurgence of
measles in São Paulo, Brazil, during 1997. This outbreak pro-
vided an opportunity to study the transmission of viruses in an
area that had previously had good measles control but then
experienced a rapid resurgence in cases. Our study showed
that a single genotype of virus, D6, was responsible for the
outbreak and that viruses from this chain of transmission sub-
sequently spread to other countries in South America. 
*Adolfo Lutz Institute, São Paulo; Brazil; †Centers for Disease Control
and Prevention, Atlanta, Georgia, USA; ‡Center for Epidemiological
Surveillance, São Paulo, Brazil; and §Institute of Biomedical Science,
São Paulo, Brazil
TEmerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 809
RESEARCH
Materials and Methods
Specimens
Samples from patients with laboratory-confirmed measles
were analyzed (Table). Six of the samples were serum speci-
mens; the rest were heparinized, whole-blood specimens.
Peripheral blood mononuclear cells (PBMC) were purified
from whole blood by using Ficoll-Hypaque gradient centrifu-
gation. The PBMC were washed three times with phosphate-
buffered saline before being resuspended in Dulbecco’s mini-
mal essential medium (DMEM) containing 10% fetal calf
serum (FCS). Aliquots of PBMC were cryopreserved by using
standard procedures (14).
Virus Isolation
B95a cells (15) were injected with 0.2 mL of the clinical
samples and maintained in DMEM, 0.2 mM L-glutamine/100
mL and gentamicin 40 mg/mL, in 2% FCS at 37°C. Samples
with no apparent cytopathic effect (CPE) after 3 passages were
discarded as negative for virus isolation. If CPE was observed,
the cells were harvested by centrifugation when CPE was
maximal, and RNA was extracted from the cell pellet. Five
measles viruses were isolated from PBMC collected during the
epidemic.
RNA Extraction, Polymerase Chain 
Reaction, and Sequencing
RNA was extracted from serum, PBMC, or infected cell
pellets by the guanidinium acid-phenol method (16). cDNA
corresponding to the nucleotides coding for the carboxyl ter-
minus of the nucleoprotein (N) or the full-length open reading
frame for the hemagglutinin (H) gene were synthesized by
using avian myeloblastosis virus reverse transcriptase (RT)
and amplified by polymerase chain reaction (PCR), and the
sequences of the PCR products were obtained as described
previously (17,18). Sequence data were analyzed by using ver-
sion 10.1 of the Genetics Computer Group Sequence Analysis
Software Package (Accelrys Inc.,  Madison, WI) (18) and phy-
logenetic analyses were performed with PAUP version 4.0
(19). A reference N gene sequence was deposited in GenBank
under accession number AF495863. 
Results
We obtained genetic information from specimens that were
collected in São Paulo from March 1995 to October 1997
(Table). During 1995 and 1996, relatively few measles cases
were reported in São Paulo; six acute-phase serum samples
were obtained from confirmed, sporadic cases that occurred as
early as 2 years before the outbreak. In 1997, a resurgence of
measles occurred in São Paulo, beginning in the fall and peak-
ing in late winter (Figure 1). Twenty-three samples were
obtained from cases that occurred during the first 42 weeks of
1997; 11 of these samples were obtained in August 1997 dur-
ing the peak of the outbreak (Table). We obtained most of the
outbreak specimens from young adults, which is consistent
with the observation that most of the measles cases occurred in
unvaccinated, young adults (6). Measles-specific immunoglo-
bulin (Ig) M responses were detected in all the patients listed
in the Table, except one. The serum sample from case number
802 was negative, probably because it was obtained <3 days
after rash onset. However, this case was confirmed by a posi-
tive virus isolation (Table). 
Virus isolation was not attempted for the serum samples,
but five virus isolates were obtained from the PBMC speci-
mens (Table) obtained during 1997. The sequences coding for
the carboxyl terminus of the nucleoprotein (456 nucleotides)
of these isolates were compared with the sequences of the
WHO reference strains (12). The results indicated that these
Brazilian viruses all had identical N gene sequences and were
members of genotype D6 (Figure 2). The N gene sequence of
MVi/SãoPaulo.BRA/42.97/35175 has been deposited in Gen-
Bank (accession no. AF495863) as a reference sequence for
this outbreak. The complete sequence of the H gene was also
obtained for MVi/SãoPaulo.BRA/42.97/35175. Comparison of
this H gene sequence with the sequences of the H genes from
the WHO reference strains confirmed the placement of these
viruses in genotype D6 (data not shown).
For the rest of the specimens from 1997, nucleotide
sequences were obtained from PCR products that were ampli-
fied directly from RNA extracted from the PBMC specimens.
In most cases, we had to perform a nested PCR reaction to get
sufficient material for sequencing. All specimens obtained in
1997, either just before or during the peak of the outbreak,
were placed in genotype D6. Most of the N gene sequences
obtained from these specimens were identical to each other
and to the N gene sequences obtained from the five isolates
from 1997. Only three of the specimens had sequences that
differed from the majority sequence by a single nucleotide. 
We were also able to amplify measles-specific PCR prod-
ucts from the serum samples obtained from sporadic measles
cases that occurred in 1995 and 1996. Two of these specimens
had nucleotide sequences in genotype A, which contains all
vaccine viruses. Both specimens were obtained from 9-month-
old infants who had received their measles vaccination 12–13
days before collection of the serum specimen. One of the sam-
ples obtained in 1995 had an N gene sequence in genotype D5,
while the other three serum samples had sequences in geno-
type D6 identical to the D6 sequences obtained during the out-
break. These data showed that D6 viruses and wild-type
viruses from genotypes other than D6 were present in São
Paulo as early as 2 years before the peak of the outbreak in
1997. 
We compared the N gene sequences from the genotype D6
viruses in the São Paulo cases with N gene sequences from
genotype D6 viruses isolated in other parts of South America
(20–24) and the world (Figure 2). For simplicity, three repre-
sentative sequences from the South American viruses are
shown in the phylogenetic tree. The sequences from the São
Paulo outbreak were identical to those obtained from viruses
isolated in Brazil (i.e.,Valenca, Rio de Janeiro, Belo Horizonte,RESEARCH
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Table. Summary of 41 measles specimens analyzed, São Paulo, Brazil, March 1995–October 1997
Namea IDb Age 
Date of specimen 
collection Vaccination statusc Genotypea
MVs/São Paulo.BRA/10.95 205* 9 m 03/09/95 02/24/95 A
MVs/São Paulo.BRA/35.95/2 258* 9 m 08/30/95 Yes D5
MVs/São Paulo.BRA/35.95/1 2793* 9 m 08/29/95 08/19/95 D6
MVs/São Paulo.BRA/3.96 141* 9 m 01/15/96 01/03/96 A
MVs/São Paulo.BRA/5.96 431* 9 m 02/26/96 02/08/96 D6
MVs/São Paulo.BRA/27.96 1490* 9 m 07/03/96 06/15/96 D6
MVs/São Paulo.BRA/4.27 106 25 yr 01/20/97 No D6
MVs/São Paulo.BRA/6.97 267 20 yr 02/04/97 Yes D6
MVs/São Paulo.BRA/9.97 503 30 yr 03/01/97 Unknown D6
MVs/São Paulo.BRA/10.97 561 24 yr 03/06/97 Unknown D6
MVs/São Paulo.BRA/11.97 661 20 yr 03/11/97 No D6
MVs/São Paulo.BRA/12.97/3 760 27 yr 03/18/97 No D6
MVs/São Paulo.BRA/12.97/1 764 23 yr 03/17/97 Unknown D6
MVs/São Paulo.BRA/12.97/2 765 31 yr 03/17/97 No D6
MVi/São Paulo.BRA/12.97/4 802 29 yr 03/18/97 No D6
MVs/São Paulo.BRA/12.97/5 862 26 yr 03/18/97 Unknown D6
MVs/São Paulo.BRA/14.97/2 1045 6 m 04/02/97 No D6
MVs/São Paulo.BRA/14.97/3 1048 27 yr 04/02/97 No D6
MVs/São Paulo.BRA/14.97/1 1084 3 m 04/01/97 No D6
MVs/São Paulo.BRA/15.97/1 1225 4 m 04/07/97 No D6
MVi/São Paulo.BRA/14.97/4 1139 22 yr 04/03/97 No D6
MVs/São Paulo.BRA/15.97/2 1202 2 yr 04/10/97 Unknown D6
MVs/São Paulo.BRA/17.97/1 1398 15 yr 04/23/97 No D6
MVi/São Paulo.BRA/17.97/3 1494 33 yr 04/27/97 No D6
MVs/São Paulo.BRA/17.97/2 8954 3 yr 04/25/97 Yes D6
MVs/São Paulo.BRA/32.97 9462 20 yr 08/21/97 Unknown D6
MVi/São Paulo.BRA/33.97/1 9463 25 yr 08/12/97 No D6
MVs/São Paulo.BRA/33.97/2 9778 24 yr 08/13/97 Unknown D6
MVs/São Paulo.BRA/30.97 9786 - 07/22/97 Yes D6
MVs/São Paulo.BRA/34.97/4 10085 3 m 08/21/97 No D6
MVs/São Paulo.BRA/33.97/5 10171 30 yr 08/15/97 No D6
MVs/São Paulo.BRA/33.97/6 10172 26 yr 08/15/97 Unknown D6
MVs/São Paulo.BRA/33.97/3 10173 5 m 08/14/97 No D6
MVs/São Paulo.BRA/33.97/4 10175 24 yr 08/14/97 Unknown D6
MVs/São Paulo.BRA/33.97/8 10179 28 yr 08/16/97 Unknown D6
MVs/São Paulo.BRA/33.97/9 10181 22 yr 08/17/97 Yes D6
MVs/São Paulo.BRA/34.97/1 10242 25 yr 08/19/97 No D6
MVs/São Paulo.BRA/33.97/7 10660 20 yr 08/15/97 Yes D6
MVs/São Paulo.BRA/34.97/2 10661 3 yr 08/19/97 No D6
MVs/São Paulo.BRA/34.97/3 10705 31 yr 08/21/97 Unknown D6
MVi/São Paulo.BRA/42.97 35175 4 m 10/14/97 No D6
aSequence name and genotype designation based on nomenclature established by World Health Organization (11). 
bID, specimen identification number. All samples were from purified peripheral blood mononuclear lymphocytes except for serum samples, designated by an asterisk. 
cDate of last measles vaccination, if known.Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 811
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Angra do Reis, and Curitiba) (20,21), Argentina (22,23), Uru-
guay (24), and Bolivia in 1997 and 1998. This homogenous
group also included two viruses that were imported into the
United States from Brazil in 1997 (25). The sequences from
genotype D6 viruses imported into the United States (26,
unpub. data) from European sources and genotype D6 viruses
isolated in Europe (27,28) were slightly different from the
South American D6 group. We found that the sequences from
the South American viruses were most closely related to a gen-
otype D6 virus isolated in Luxembourg in 1997, although no
foreign source was identified for the outbreak in Brazil. Over-
all, the N genes sequences of D6 viruses within the South
American group differed by no more than 0.4% but differed
from other genotype D6 sequences by as much as 1.4%. 
Discussion
This report presents the virologic surveillance data from
the measles outbreak that occurred in São Paulo, Brazil, during
1997. Sequence data from the specimens obtained during the
outbreak indicated the presence of measles viruses belonging
to genotype D6, which is one of the prevalent genotypes of
measles virus in Europe. Frequently associated with imported
measles cases from European countries (8,26), D6 viruses
have been isolated in the United Kingdom, Spain, Germany,
Russia, Poland, Denmark, and Luxembourg (27–31). During
1997–2000, these genotype D6 viruses were imported into the
United States from Italy, Greece, Ukraine, Croatia, Cyprus,
and the United Kingdom, and from the large measles outbreak
that occurred in São Paulo (Rota, unpub. data). However,
because neither conventional case nor virologic surveillance
was conducted in Brazil before the start of the measles control
program in 1991, it is not possible to determine if the D6
viruses were recently introduced into Brazil by importation or
if they represent continued circulation of viruses indigenous to
Brazil. Our data show that D6 viruses indistinguishable from
the D6 viruses isolated during the São Paulo outbreak were
responsible for sporadic measles cases in São Paulo for at least
2 years before the outbreak. In a large urban area such as São
Paulo, the virus will likely be continually present either from
low-level circulation or frequent importation. In late 1997, a
change occurred in the epidemiologic circumstances, resulting
in a large outbreak of the measles virus. Factors that contrib-
uted to the outbreak included the failure to conduct a timely
follow-up vaccination campaign in 1995 and the low level of
vaccination coverage among infants achieved by routine
health services. Additionally, a large number of unvaccinated
young adults who had escaped measles infection had moved to
São Paulo from rural areas. The high population density in São
Paulo also facilitated rapid spread of the virus (7). 
Laboratory-based surveillance for measles was established
in Brazil in the early 1990s. Although virologic surveillance
was certainly incomplete, some information is available about
measles genotypes present in Brazil before the 1997 outbreak
in São Paulo. Genotype D5 was detected in a sporadic case in
São Paulo in 1995 and in sporadic cases that occurred in the
state of Bahia in 1996 (21). Genotype D5 viruses that circulate
in Japan have been associated with importation of viruses from
Japan into other countries (26,32,33). The source of the geno-
type D5 viruses detected in São Paulo and Bahia was not iden-
tified. Genotype C2 viruses were detected in a small outbreak
in the state of Santa Catarina in 1996 (21). C2, another indige-
nous genotype in Europe, is often associated with imported
cases in other parts of the world (27–31).
Fever and rash occur in approximately 5% of measles vac-
cine recipients (34). In areas where wild-type virus is circulat-
ing, vaccine reactions may be classified as measles cases.
Distinguishing a vaccine reaction from a measles case is not
possible with the currently available serologic methods. Only
the genetic analysis of virus isolates can confirm the presence
of either a vaccine or wild-type virus. In this study, two vac-
Figure 1. Number of measles cases, by week, São Paulo, Brazil, 1997.
Figure 2. Phylogenetic relationships of the N gene sequences from
genotype D6 viruses from Brazilian, South American, and European
sources. Tree shows representative genotype D6 sequences from Bra-
zil, Argentina, Uruguay, and Bolivia, and viruses imported into the
United States from Brazil (South American cluster) compared with gen-
otype D6 sequences of viruses isolated in Europe or imported into the
United States from European sources. Also shown are the sequences
of the World Health Organization reference strains for each genotype.RESEARCH
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cine viruses were detected in persons who had received vac-
cine 12 and 13 days before collection of specimens. In vaccine
reactions, rash and fever typically occur 7 to 12 days after vac-
cination; the virus can be detected in circulating lymphocytes
even after the rash and fever have resolved. 
The situation in Brazil is now very similar to that in the
United States in the early 1990s. From 1989 to 1991, the
United States experienced a resurgence of measles, with
>50,000 reported cases. Virologic surveillance suggested that
virus from a single genotype, D3, had seeded the entire coun-
try. As was the case with the D6 viruses from South America,
the D3 viruses from many different areas in the United States
had nearly identical sequences (8). Therefore, we conclude
that when measles outbreaks occur in areas that have good
measles control, genetic analysis of viruses will confirm the
presence of a single chain of transmission. In contrast, in areas
where measles control programs are less advanced, genetic
studies have identified multiple chains of transmission within
a genotype (17). 
Initiation of a two-dose vaccination schedule, along with
the success of the PAHO strategy in the Americas, resulted in
historically low numbers of cases in the United States in the
years following the resurgence there; both standard epidemio-
logic surveillance and molecular epidemiologic surveillance
have documented the sustained interruption of transmission of
the genotype D3 viruses (1,2,8,35–37). Similarly, the pattern
of viral genotypes found in Brazil and other parts of South and
Central America will help to assess the success of the PAHO
measles control programs. Genotype D6 viruses were circulat-
ing in Haiti and the Dominican Republic during 2001 but have
not been isolated from ongoing chains of transmission in any
other countries in the region (36). During 2002, virologic sur-
veillance showed that measles cases imported into El Salvador
from Europe were genotype D7 (38). As the number of mea-
sles cases continues to decrease in the Americas, increasing
virologic surveillance activities will be important. This viro-
logic surveillance will document the interruption of indige-
nous transmission of the genotype D6 viruses in Brazil and in
other parts of South America. 
Dr. Oliviera is a research scientist at the Adolfo Lutz Institute,
São Paulo, Brazil. Her research interests include diagnosis of
exantematic viral diseases and molecular epidemiology of exantem-
atic viral diseases, including measles, rubella, parvovirus B19 and
herpevirus 6.
References
  1. Centers for Disease Control and Prevention. Progress toward interrupting
indigenous measles transmission - region of the Americas, January–
November 2001. JAMA 2002;287:709–10.
    2. Centers for Disease Control and Prevention. Measles—United States.
MMWR Morb Mortal Wkly Rep 2000;49:557–60.
    3. World Health Organization. Expanded Programme on Immunization.
Measles control. Geneva: The Organization; document WHO/EPI/GEN/
92.3; 1992. p. 1–34.
  4. de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA,
Brandling-Bennett D, et al. Measles elimination in the Americas. Evolv-
ing strategies. JAMA 1996;275:224–9.
  5. Centers for Disease Control and Prevention. Progress toward elimination
of measles from the Americas. MMWR Morb Mortal Wkly Rep
1998;47:189–93.
  6. Camargo MCC, de Moraes JC, Souza VA, Matos MR, Pannuti CS. Pre-
dictors related to the occurence of a measles epidemic in the city of São
Paulo in 1997. Rev Panam Salud Publica 2000;7:359–65.
  7. Hersh BS, Tambini G, Nogueira AC, Carrasco P, de Quadros CA. Review
of measles surveillance data in the Americas, 1996–1999. Lancet
2000;355:1943–8.
  8. Rota JS, Health JL, Rota PA, King GE, Jin L, Brown DWB, et al. Molec-
ular epidemiology of measles virus: identification of pathways of trans-
mission and implications for measles elimination. J Infect Dis
1996;73:32–7.
    9. Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses:
implications for global measles elimination programs. Emerg Infect Dis
1998;4:29–35.
10. Rota JR, Bellini WJ, Rota PA. Measles. In: Thompson RCA, editor.
Molecular epidemiology of infectious diseases. London: Kluwer Aca-
demic & Lippincott Raven Publishers; 2000. p. 168–80.
11. World Health Organization. Standardization of the nomenclature for
describing the genetic characteristics of wild-type measles viruses. Wkly
Epidemiol Rec 1998;73:265–72.
12. World Health Organization. Nomenclature for describing the genetic
characteristics of wild-type measles viruses (update). Part I. Wkly Epide-
miol Rec 2001;76:242–7.
13. World Health Organization. Nomenclature for describing the genetic
characteristics of wild-type measles viruses (update). Wkly Epidemiol
Rec 2001;76:249–51.
14. Baseler MW, Stevens RA, Metcalf JA. Immunologic monitoring of
patients with human immunodeficiency virus. In: Rose NR, DeMarcario
EC, Fahay JL, Friedman H, Penn GM, editors. Manual of clinical labora-
tory immunology. 4th ed. Washington: American Society for Microbiol-
ogy; 1992. p. 377.
15. Kobune F, Sakata H, Sugiura A. Marmoset lymphoblastoid cells as a sen-
sitive host for isolation of measles virus. J Virol 1990;64:700–5.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem
1987;162:156–9.
17. Liffick S, Thoung N, Xu W, Li Y, Lien H, Bellini WJ, et al. Genetic char-
acterization of contemporary wild-type viruses from Vietnam and China:
identification of two genotypes within clade H. Virus Res 2001;77:81–7.
18. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence
analysis programs for the VAX . Nucleic Acids Res 1984;12:387–95.
19. Swofford DL. PAUP: phylogenetic analysis using parsimony. Version
3.1.1 Champaign (IL): Illinois Natural History Survey; 1986.
20. Oliveira I, Curti SP, Figueiredo CA, Afonso MAS, Theobalso  M, Souza
LTM, et al. Genetic analysis of measles virus in São Paulo, Brazil. Virus
Rev Res 1998;3:7–8.
21. Siqueira MM, Castro-Silva R, Cruz C, Oliveira IC, Cunha GMC, Mello
M, et al. Genomic characterization of wild-type measles viruses that cir-
culated in different states during the 1997 measles epidemic. J Med Virol
2001;63:299–304.
22. Barrero PR, de Wolff CD, Passeggi CA, Mistchenko AS. Sequence analy-
sis of measles virus hemagglutinin isolated in Argentina during the 1997–
1998 outbreak. J Med Virol 2000;60:91–6.
23. Baumeister E, Siqueira MM, Savy V, Friedrich F. Genetic characteriza-
tion of wild-type measles viruses isolated during the 1998 measles epi-
demic in Argentina. Acta Virol 2000;44: 169–74.
24. Canepa E, Siqueira M, Hortal M, Friedrich F. Recent measles viral activ-
ity in Uruguay: serological and genetic approaches. Acta Virol
2000;44:35–9.Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 813
RESEARCH
25. Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, et al. Molec-
ular epidemiology of measles viruses in the United States: 1997–2001.
Emerg Infect Dis 2002 (in press).
26. Rota JS, Rota PA, Redd SB, Pattamadilok S, Bellini WJ. Genetic analysis
of measles viruses isolated in the United States, 1995-1996. J Infect Dis
1998;177:204–8.
27. Santibanez S, Heider A, Gerike E, Agafonov A, Schreier E. Genotyping
of measles virus isolates from central Europe and Russia. J Med Virol
1999;58:313–20.
28. Hanses F, van Binnendijk R, Ammerlaan W, Truong AT, de Rond L,
Schneider F, et al. Genetic variability of measles viruses circulating in the
Benelux. Arch Virol 2001;145:541–51.
29. Rima BK, Earle JAP, Yeo RP, Herlihy L, Baczko K, ter Meulen V, et al.
Temporal and geographical distribution of measles virus genotypes. J Gen
Virol 1995;76:1173–80.
30. Rima BK, Earle JAP, Baczko K, ter Meulen V, Liebert U, Carstens C, et
al. Sequence divergence of measles virus hemagglutinin during natural
evolution and adaptation to cell culture. J Gen Virol 1997;78: 97–106.
31. Jin L, Brown DWG, Ramsay MEB, Rota PA, Bellini WJ. The diversity of
measles virus in the UK, 1992–1995. J Gen Virol 1997;78:1287–94.
32. Yamaguchi S. Identification of three lineages of wild measles virus by
nucleotide sequence analysis of the N, P, M, F and L genes in Japan. J
Med Virol 1997;52:113–26.
33. Katayama Y, Shibahara K, Kohama T, Homma M, Hotta H. Molecular
epidemiology and changing distribution of genotypes of measles virus
field strains in Japan. J Clin Microbiol 1997;35:2651–63.
34. Redd SC, Markowitz LE, Katz SL. In: Plotkin SA, Orenstein WA, editors.
Vaccines 3rd ed. Philadelphia: WB Saunders & Co.; 1999. p. 222–66.
35. Centers for Disease Control and Prevention. Absence of reported mea-
sles—United States. MMWR Morb Mortal Wkly Rep 1993;48:925–6.
36. Centers for Disease Control and Prevention. Progress toward interrupting
indigenous measles transmission: Region of the Americas, January 1999.
MMWR Morb Mortal Wkly Rep 2000;49:986–90
37. Centers for Disease Control and Prevention. Measles—United States,
1996, and the interruption of indigenous transmission. MMWR Morb
Mortal Wkly Rep 1997;46:242–6.
38. Pan American Health Organization. Measles in El Salvador. EPI Newslet-
ter 2001;23:1–3.
Address for correspondence:  Paul A. Rota, Measles Virus Section, MS C22,
Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA
30333, USA; fax: 404-639-4187; e-mail: prota@cdc.gov